Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IA Open Label Pharmaco- Magnetic Resonance Spectrography (MRS) Study of Clavulanic Acid Daily Repeated Administration in Remitted Cocaine Use Disorder Subjects

NCT03986762 is registered in ClinicalTrials.gov with Temple University as lead sponsor.

NCT NCT03986762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03986762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IA Open Label Pharmaco- Magnetic Resonance Spectrography (MRS) Study of Clavulanic Acid Daily Repeated Administration in Remitted Cocaine Use Disorder Subjects
Lead sponsor
Temple University
Phase
Phase 1
Overall status
Completed
Start date
March 12, 2019
Completion date
December 20, 2019
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine abuse, in remission, cocaine dependence, in remission, cocaine-related disorders